Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

被引：0
作者：
Peter Bannas
Thorsten Derlin
Michael Groth
Ivayla Apostolova
Gerhard Adam
Janos Mester
Susanne Klutmann
机构：
[1] University Medical Center Hamburg-Eppendorf,Department of Diagnostic and Interventional Radiology
[2] University Medical Center Hamburg-Eppendorf,Department of Nuclear Medicine
[3] Charité-Universitätsmedizin Berlin,Department of Nuclear Medicine
来源：
Annals of Nuclear Medicine | 2012年 / 26卷
关键词：
Thyroid cancer; Negative radioiodine whole body scan; F-FDG-PET/CT; PET/CT; Differentiated thyroid carcinoma; Thyroglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 85
页数：8
相关论文
共 146 条
[1]  
Schlumberger MJ(1998)Papillary and follicular thyroid carcinoma N Engl J Med 338 297-306
[2]  
Filesi M(1998)Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases J Nucl Med 39 1542-1546
[3]  
Signore A(2003)Thyroid carcinoma Lancet 361 501-511
[4]  
Ventroni G(2000)Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma Surgery 128 1067-1074
[5]  
Melacrinis FF(1999)Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status J Endocrinol Invest 22 3-7
[6]  
Ronga G(2006)The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature Q J Nucl Med Mol Imaging 50 78-87
[7]  
Sherman SI(2001)Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative J Nucl Med 42 71-76
[8]  
Frilling A(2000)I scan J Nucl Med 41 1010-1015
[9]  
Gorges R(2008)FDG PET of recurrent or metastatic J Nucl Med 49 938-955
[10]  
Tecklenborg K(2004)I-negative papillary thyroid carcinoma J Nucl Med 45 2045-2051
12345678910